,x,y,v,Subtypes,colors
0,0,0,DPRA1: Distribution of 0.25A,Transcript related,#fb9a99
1,0,1,LFIB1: Lipoaffinity index_3 distribution of 0.25B,Solubility lipoaffinity,#33a02c
2,0,2,SLFB1: Sum of path lengths starting from oxygens_3 distribution of 0.25B,Topological indice,#cab2d6
3,0,3,DPRA2: Distribution of 0.50A,Transcript related,#fb9a99
4,0,4,LFIB2: Lipoaffinity index_3 distribution of 0.50B,Solubility lipoaffinity,#33a02c
5,0,5,TPSC1: Topological polar surface area_3 distriCution of 0.25C,Topological indice,#cab2d6
6,0,6,DPRG1: Distribution of 0.25G,Transcript related,#fb9a99
7,0,7,LFIC1: Lipoaffinity index_3 distriCution of 0.25C,Solubility lipoaffinity,#33a02c
8,0,8,PHBC1: Potential Hydrogen Bonds_3 distriCution of 0.25C,Hydrogen bond related,#6a3d9a
9,0,9,SHDB1: Strong H-Bond donors distribution of 0.25B,Hydrogen bond related,#6a3d9a
10,0,10,LFIC2: Lipoaffinity index_3 distriCution of 0.50C,Solubility lipoaffinity,#33a02c
11,0,11,SHDB2: Strong H-Bond donors distribution of 0.50B,Hydrogen bond related,#6a3d9a
12,0,12,SLFA1: Sum of path lengths starting from oxygens_3 distribution of 0.25A,Topological indice,#cab2d6
13,0,13,DPRG0: Distribution of 0.00G,Transcript related,#fb9a99
14,0,14,LFIC0: Lipoaffinity index_3 distriCution of 0.00C,Solubility lipoaffinity,#33a02c
15,0,15,SHDB0: Strong H-Bond donors distribution of 0.00B,Hydrogen bond related,#6a3d9a
16,0,16,PHBC0: Potential Hydrogen Bonds_3 distriCution of 0.00C,Hydrogen bond related,#6a3d9a
17,0,17,PSNA0: Primary or secondary nitrogens distribution of 0.00A,Topological indice,#cab2d6
18,0,18,TPSC0: Topological polar surface area_3 distriCution of 0.00C,Topological indice,#cab2d6
19,0,19,LFIB0: Lipoaffinity index distribution of 0.00B,Solubility lipoaffinity,#33a02c
20,0,20,SLFB0: Sum of path lengths starting from oxygens_3 distribution of 0.00B,Topological indice,#cab2d6
21,0,21,SHAB0: Strong H-Bond acceptors_3 distribution of 0.00B,Hydrogen bond related,#6a3d9a
22,0,22,DPRA0: Distribution of 0.00A,Transcript related,#fb9a99
23,0,23,MLFA0: Linear free energy distribution of 0.00A,Hydrogen bond related,#6a3d9a
24,0,24,PHBA0: Potential Hydrogen Bonds_3 distribution of 0.00A,Hydrogen bond related,#6a3d9a
25,0,25,LFIB0: Lipoaffinity index_3 distribution of 0.00B,Solubility lipoaffinity,#33a02c
26,0,26,DPRT0: Distribution of 0.00T,Transcript related,#fb9a99
27,0,27,TPSB0: Topological polar surface area_3 distribution of 0.00B,Topological indice,#cab2d6
28,1,0,SHAB1: Strong H-Bond acceptors_3 distribution of 0.25B,Hydrogen bond related,#6a3d9a
29,1,1,LFIB1: Lipoaffinity index distribution of 0.25B,Solubility lipoaffinity,#33a02c
30,1,2,SHAB2: Strong H-Bond acceptors_3 distribution of 0.50B,Hydrogen bond related,#6a3d9a
31,1,3,LFIB2: Lipoaffinity index distribution of 0.50B,Solubility lipoaffinity,#33a02c
32,1,4,DPRA3: Distribution of 0.75A,Transcript related,#fb9a99
33,1,5,SHAB3: Strong H-Bond acceptors_3 distribution of 0.75B,Hydrogen bond related,#6a3d9a
34,1,6,DPRG2: Distribution of 0.50G,Transcript related,#fb9a99
35,1,7,PHBC3: Potential Hydrogen Bonds_3 distriCution of 0.75C,Hydrogen bond related,#6a3d9a
36,1,8,TPSC2: Topological polar surface area_3 distriCution of 0.50C,Topological indice,#cab2d6
37,1,9,LFIC3: Lipoaffinity index_3 distriCution of 0.75C,Solubility lipoaffinity,#33a02c
38,1,10,PHBC2: Potential Hydrogen Bonds_3 distriCution of 0.50C,Hydrogen bond related,#6a3d9a
39,1,11,SHDB3: Strong H-Bond donors distribution of 0.75B,Hydrogen bond related,#6a3d9a
40,1,12,MLFB1: Linear free energy distribution of 0.25B,Hydrogen bond related,#6a3d9a
41,1,13,MLFB2: Linear free energy distribution of 0.50B,Hydrogen bond related,#6a3d9a
42,1,14,DPRC1: Distribution of 0.25C,Transcript related,#fb9a99
43,1,15,HPCB1: Gas-hexadecane PC distribution of 0.25B,Partition coefficient,#a6cee3
44,1,16,HPCB1: Gas-hexadecane PC_3 distribution of 0.25B,Partition coefficient,#a6cee3
45,1,17,PHBB1: Potential Hydrogen Bonds_3 distribution of 0.25B,Hydrogen bond related,#6a3d9a
46,1,18,SHAC1: Strong H-Bond acceptors_3 distriCution of 0.25C,Hydrogen bond related,#6a3d9a
47,1,19,SHAC0: Strong H-Bond acceptors_3 distriCution of 0.00C,Hydrogen bond related,#6a3d9a
48,1,20,HPCB0: Gas-hexadecane PC distribution of 0.00B,Partition coefficient,#a6cee3
49,1,21,DPRC0: Distribution of 0.00C,Transcript related,#fb9a99
50,1,22,HPCB0: Gas-hexadecane PC_3 distribution of 0.00B,Partition coefficient,#a6cee3
51,1,23,PHBB0: Potential Hydrogen Bonds_3 distribution of 0.00B,Hydrogen bond related,#6a3d9a
52,1,24,PSNB0: Primary or secondary nitrogens distribution of 0.00B,Topological indice,#cab2d6
53,1,25,SLFC0: Sum of path lengths starting from oxygens_3 distriCution of 0.00C,Topological indice,#cab2d6
54,1,26,HPCC0: Gas-hexadecane PC_3 distriCution of 0.00C,Partition coefficient,#a6cee3
55,1,27,SCDCC: Series correlation PseDN composition of CC,Nucleotide related,#b2df8a
56,2,0,SLFC1: Sum of path lengths starting from oxygens_3 distriCution of 0.25C,Topological indice,#cab2d6
57,2,1,PSNB1: Primary or secondary nitrogens distribution of 0.25B,Topological indice,#cab2d6
58,2,2,HPCC1: Gas-hexadecane PC_3 distriCution of 0.25C,Partition coefficient,#a6cee3
59,2,3,SLFB2: Sum of path lengths starting from oxygens_3 distribution of 0.50B,Topological indice,#cab2d6
60,2,4,LFIB3: Lipoaffinity index_3 distribution of 0.75B,Solubility lipoaffinity,#33a02c
61,2,5,LFIB3: Lipoaffinity index distribution of 0.75B,Solubility lipoaffinity,#33a02c
62,2,6,SLFB3: Sum of path lengths starting from oxygens_3 distribution of 0.75B,Topological indice,#cab2d6
63,2,7,HPCA3: Gas-hexadecane PC_3 distribution of 0.75A,Partition coefficient,#a6cee3
64,2,8,MReA1: Molar refractivity distribution of 0.25A,Polarizability refractivity,#1f78b4
65,2,9,DPRG3: Distribution of 0.75G,Transcript related,#fb9a99
66,2,10,TPSC3: Topological polar surface area_3 distriCution of 0.75C,Topological indice,#cab2d6
67,2,11,C5UTR: Coverage of 5 untranslated region,Transcript related,#fb9a99
68,2,12,SLFA3: Sum of path lengths starting from oxygens_3 distribution of 0.75A,Topological indice,#cab2d6
69,2,13,SLFA2: Sum of path lengths starting from oxygens_3 distribution of 0.50A,Topological indice,#cab2d6
70,2,14,SHAC3: Strong H-Bond acceptors_3 distriCution of 0.75C,Hydrogen bond related,#6a3d9a
71,2,15,HPCB3: Gas-hexadecane PC distribution of 0.75B,Partition coefficient,#a6cee3
72,2,16,SHAC2: Strong H-Bond acceptors_3 distriCution of 0.50C,Hydrogen bond related,#6a3d9a
73,2,17,HPCB2: Gas-hexadecane PC distribution of 0.50B,Partition coefficient,#a6cee3
74,2,18,HPCB2: Gas-hexadecane PC_3 distribution of 0.50B,Partition coefficient,#a6cee3
75,2,19,PHBB2: Potential Hydrogen Bonds_3 distribution of 0.50B,Hydrogen bond related,#6a3d9a
76,2,20,DPRC2: Distribution of 0.50C,Transcript related,#fb9a99
77,2,21,MRe: Molar refractivity00,Polarizability refractivity,#1f78b4
78,2,22,HPC: Gas-hexadecane PC_3000,Partition coefficient,#a6cee3
79,2,23,TraEE: Entropy density E on transcript,Transcript related,#fb9a99
80,2,24,ORFEG: Entropy density G on ORF,Open reading frame,#ff7f00
81,2,25,TraEG: Entropy density G on transcript,Transcript related,#fb9a99
82,2,26,SHD: Strong H-Bond donors011,Hydrogen bond related,#6a3d9a
83,2,27,PCDCC: Parallel correlation PseDN composition of CC,Nucleotide related,#b2df8a
84,3,0,DPRT1: Distribution of 0.25T,Transcript related,#fb9a99
85,3,1,TPSB1: Topological polar surface area_3 distribution of 0.25B,Topological indice,#cab2d6
86,3,2,SLFC2: Sum of path lengths starting from oxygens_3 distriCution of 0.50C,Topological indice,#cab2d6
87,3,3,MLFA1: Linear free energy distribution of 0.25A,Hydrogen bond related,#6a3d9a
88,3,4,PHBA1: Potential Hydrogen Bonds_3 distribution of 0.25A,Hydrogen bond related,#6a3d9a
89,3,5,MLFA2: Linear free energy distribution of 0.50A,Hydrogen bond related,#6a3d9a
90,3,6,PHBA3: Potential Hydrogen Bonds_3 distribution of 0.75A,Hydrogen bond related,#6a3d9a
91,3,7,SHDA2: Strong H-Bond donors distribution of 0.50A,Hydrogen bond related,#6a3d9a
92,3,8,MReA2: Molar refractivity distribution of 0.50A,Polarizability refractivity,#1f78b4
93,3,9,HPCA2: Gas-hexadecane PC_3 distribution of 0.50A,Partition coefficient,#a6cee3
94,3,10,HPCA1: Gas-hexadecane PC_3 distribution of 0.25A,Partition coefficient,#a6cee3
95,3,11,PSNA2: Primary or secondary nitrogens distribution of 0.50A,Topological indice,#cab2d6
96,3,12,PSNA3: Primary or secondary nitrogens distribution of 0.75A,Topological indice,#cab2d6
97,3,13,PSNA1: Primary or secondary nitrogens distribution of 0.25A,Topological indice,#cab2d6
98,3,14,MLFB3: Linear free energy distribution of 0.75B,Hydrogen bond related,#6a3d9a
99,3,15,PHBB3: Potential Hydrogen Bonds_3 distribution of 0.75B,Hydrogen bond related,#6a3d9a
100,3,16,HPCB3: Gas-hexadecane PC_3 distribution of 0.75B,Partition coefficient,#a6cee3
101,3,17,DPRC3: Distribution of 0.75C,Transcript related,#fb9a99
102,3,18,HPC: Gas-hexadecane PC_30,Partition coefficient,#a6cee3
103,3,19,HPCCA: Gas-hexadecane PC_3 composition of A,Partition coefficient,#a6cee3
104,3,20,HPC: Gas-hexadecane PC_300,Partition coefficient,#a6cee3
105,3,21,PCDCA: Parallel correlation PseDN composition of CA,Nucleotide related,#b2df8a
106,3,22,ORFEE: Entropy density E on ORF,Open reading frame,#ff7f00
107,3,23,ORFER: Entropy density R on ORF,Open reading frame,#ff7f00
108,3,24,LFICC: Lipoaffinity index_3 composition of C,Solubility lipoaffinity,#33a02c
109,3,25,PHB: Potential Hydrogen Bonds_3220,Hydrogen bond related,#6a3d9a
110,3,26,PHB: Potential Hydrogen Bonds_3022,Hydrogen bond related,#6a3d9a
111,3,27,LFI: Lipoaffinity index_3220,Solubility lipoaffinity,#33a02c
112,4,0,ProII: Pseudo protein instability index,Pseudo protein related,#ffed6f
113,4,1,TPSB2: Topological polar surface area_3 distribution of 0.50B,Topological indice,#cab2d6
114,4,2,PSNB2: Primary or secondary nitrogens distribution of 0.50B,Topological indice,#cab2d6
115,4,3,DPRT2: Distribution of 0.50T,Transcript related,#fb9a99
116,4,4,PHBA2: Potential Hydrogen Bonds_3 distribution of 0.50A,Hydrogen bond related,#6a3d9a
117,4,5,MLFA3: Linear free energy distribution of 0.75A,Hydrogen bond related,#6a3d9a
118,4,6,HPCA2: Gas-hexadecane PC distribution of 0.50A,Partition coefficient,#a6cee3
119,4,7,SHDA1: Strong H-Bond donors distribution of 0.25A,Hydrogen bond related,#6a3d9a
120,4,8,SHDA3: Strong H-Bond donors distribution of 0.75A,Hydrogen bond related,#6a3d9a
121,4,9,HPCA3: Gas-hexadecane PC distribution of 0.75A,Partition coefficient,#a6cee3
122,4,10,MReA3: Molar refractivity distribution of 0.75A,Polarizability refractivity,#1f78b4
123,4,11,TPSA2: Topological polar surface area_3 distribution of 0.50A,Topological indice,#cab2d6
124,4,12,CNHA2: NH- count distribution of 0.50A,Molecular fingerprint,#8c8c8c
125,4,13,TPSA3: Topological polar surface area_3 distribution of 0.75A,Topological indice,#cab2d6
126,4,14,TPSA1: Topological polar surface area_3 distribution of 0.25A,Topological indice,#cab2d6
127,4,15,CNHA1: NH- count distribution of 0.25A,Molecular fingerprint,#8c8c8c
128,4,16,DPRA4: Distribution of 1.00A,Transcript related,#fb9a99
129,4,17,SLFB4: Sum of path lengths starting from oxygens_3 distribution of 1.00B,Topological indice,#cab2d6
130,4,18,MRe: Molar refractivity0,Polarizability refractivity,#1f78b4
131,4,19,MReCA: Molar refractivity composition of A,Polarizability refractivity,#1f78b4
132,4,20,LFI: Lipoaffinity index_3021,Solubility lipoaffinity,#33a02c
133,4,21,MRe: Molar refractivity000,Polarizability refractivity,#1f78b4
134,4,22,LFIBC: Lipoaffinity index_3 transition between B and C,Solubility lipoaffinity,#33a02c
135,4,23,TraER: Entropy density R on transcript,Transcript related,#fb9a99
136,4,24,ComRG: Composition of G,Transcript related,#fb9a99
137,4,25,PHBCC: Potential Hydrogen Bonds_3 composition of C,Hydrogen bond related,#6a3d9a
138,4,26,TPS: Topological polar surface area_3022,Topological indice,#cab2d6
139,4,27,LFI: Lipoaffinity index_3022,Solubility lipoaffinity,#33a02c
140,5,0,CC129: Cross covariance of lag1 on SLI-SKE,Nucleotide related,#b2df8a
141,5,1,CC127: Cross covariance of lag1 on SLI-BDS,Nucleotide related,#b2df8a
142,5,2,HPCC2: Gas-hexadecane PC_3 distriCution of 0.50C,Partition coefficient,#a6cee3
143,5,3,TPSB3: Topological polar surface area_3 distribution of 0.75B,Topological indice,#cab2d6
144,5,4,PSNB3: Primary or secondary nitrogens distribution of 0.75B,Topological indice,#cab2d6
145,5,5,MReB2: Molar refractivity distribution of 0.50B,Polarizability refractivity,#1f78b4
146,5,6,LFIA2: Lipoaffinity index_3 distribution of 0.50A,Solubility lipoaffinity,#33a02c
147,5,7,MReB3: Molar refractivity distribution of 0.75B,Polarizability refractivity,#1f78b4
148,5,8,HPCA1: Gas-hexadecane PC distribution of 0.25A,Partition coefficient,#a6cee3
149,5,9,LFIA3: Lipoaffinity index distribution of 0.75A,Solubility lipoaffinity,#33a02c
150,5,10,SHDA4: Strong H-Bond donors distribution of 1.00A,Hydrogen bond related,#6a3d9a
151,5,11,MLFA4: Linear free energy distribution of 1.00A,Hydrogen bond related,#6a3d9a
152,5,12,HPCA4: Gas-hexadecane PC distribution of 1.00A,Partition coefficient,#a6cee3
153,5,13,MReA4: Molar refractivity distribution of 1.00A,Polarizability refractivity,#1f78b4
154,5,14,CNHA3: NH- count distribution of 0.75A,Molecular fingerprint,#8c8c8c
155,5,15,SHAB4: Strong H-Bond acceptors_3 distribution of 1.00B,Hydrogen bond related,#6a3d9a
156,5,16,LFIB4: Lipoaffinity index_3 distribution of 1.00B,Solubility lipoaffinity,#33a02c
157,5,17,MRe: Molar refractivity001,Polarizability refractivity,#1f78b4
158,5,18,TraED: Entropy density D on transcript,Transcript related,#fb9a99
159,5,19,PHB: Potential Hydrogen Bonds_320,Hydrogen bond related,#6a3d9a
160,5,20,SCDCA: Series correlation PseDN composition of CA,Nucleotide related,#b2df8a
161,5,21,TraAG: Transition between A and G,Transcript related,#fb9a99
162,5,22,SHD: Strong H-Bond donors01,Hydrogen bond related,#6a3d9a
163,5,23,TPS: Topological polar surface area_320,Topological indice,#cab2d6
164,5,24,TPSCC: Topological polar surface area_3 composition of C,Topological indice,#cab2d6
165,5,25,SHDCB: Strong H-Bond donors composition of B,Hydrogen bond related,#6a3d9a
166,5,26,SHD: Strong H-Bond donors110,Hydrogen bond related,#6a3d9a
167,5,27,TPS: Topological polar surface area_3220,Topological indice,#cab2d6
168,6,0,ASLI1: Dinucleotide auto covariance of lag1 on SLI,Nucleotide related,#b2df8a
169,6,1,CC128: Cross covariance of lag1 on SLI-ETI,Nucleotide related,#b2df8a
170,6,2,CC215: Cross covariance of lag2 on ETI-SLI,Nucleotide related,#b2df8a
171,6,3,DPRT3: Distribution of 0.75T,Transcript related,#fb9a99
172,6,4,SLFC3: Sum of path lengths starting from oxygens_3 distriCution of 0.75C,Topological indice,#cab2d6
173,6,5,LFIA1: Lipoaffinity index_3 distribution of 0.25A,Solubility lipoaffinity,#33a02c
174,6,6,LFIA3: Lipoaffinity index_3 distribution of 0.75A,Solubility lipoaffinity,#33a02c
175,6,7,CNHB3: NH- count distribution of 0.75B,Molecular fingerprint,#8c8c8c
176,6,8,SHAA2: Strong H-Bond acceptors_3 distribution of 0.50A,Hydrogen bond related,#6a3d9a
177,6,9,LFIA2: Lipoaffinity index distribution of 0.50A,Solubility lipoaffinity,#33a02c
178,6,10,PHBA4: Potential Hydrogen Bonds_3 distribution of 1.00A,Hydrogen bond related,#6a3d9a
179,6,11,PSNA4: Primary or secondary nitrogens distribution of 1.00A,Topological indice,#cab2d6
180,6,12,CNHA4: NH- count distribution of 1.00A,Molecular fingerprint,#8c8c8c
181,6,13,HPCA4: Gas-hexadecane PC_3 distribution of 1.00A,Partition coefficient,#a6cee3
182,6,14,ProPI: Pseudo protein isoelectric point,Pseudo protein related,#ffed6f
183,6,15,LFIB4: Lipoaffinity index distribution of 1.00B,Solubility lipoaffinity,#33a02c
184,6,16,MRe: Molar refractivity100,Polarizability refractivity,#1f78b4
185,6,17,ORFED: Entropy density D on ORF,Open reading frame,#ff7f00
186,6,18,PHB: Potential Hydrogen Bonds_302,Hydrogen bond related,#6a3d9a
187,6,19,PHBAC: Potential Hydrogen Bonds_3 transition between A and C,Hydrogen bond related,#6a3d9a
188,6,20,LFI: Lipoaffinity index_3210,Solubility lipoaffinity,#33a02c
189,6,21,SCDAC: Series correlation PseDN composition of AC,Nucleotide related,#b2df8a
190,6,22,SHD: Strong H-Bond donors10,Hydrogen bond related,#6a3d9a
191,6,23,TPS: Topological polar surface area_3020,Topological indice,#cab2d6
192,6,24,TPS: Topological polar surface area_302,Topological indice,#cab2d6
193,6,25,PHB: Potential Hydrogen Bonds_3202,Hydrogen bond related,#6a3d9a
194,6,26,TPS: Topological polar surface area_3202,Topological indice,#cab2d6
195,6,27,GCC1V: GCCo1 variance frame score,Guanine-cytosine related,#fdbf6f
196,7,0,CC120: Cross covariance of lag1 on SKE-SLI,Nucleotide related,#b2df8a
197,7,1,CC130: Cross covariance of lag1 on SLI-WCI,Nucleotide related,#b2df8a
198,7,2,CC210: Cross covariance of lag2 on BDS-SLI,Nucleotide related,#b2df8a
199,7,3,CC225: Cross covariance of lag2 on WCI-SLI,Nucleotide related,#b2df8a
200,7,4,HPCC3: Gas-hexadecane PC_3 distriCution of 0.75C,Partition coefficient,#a6cee3
201,7,5,MReB1: Molar refractivity distribution of 0.25B,Polarizability refractivity,#1f78b4
202,7,6,SHAA3: Strong H-Bond acceptors_3 distribution of 0.75A,Hydrogen bond related,#6a3d9a
203,7,7,SHAA1: Strong H-Bond acceptors_3 distribution of 0.25A,Hydrogen bond related,#6a3d9a
204,7,8,CNHB1: NH- count distribution of 0.25B,Molecular fingerprint,#8c8c8c
205,7,9,LFIA1: Lipoaffinity index distribution of 0.25A,Solubility lipoaffinity,#33a02c
206,7,10,SHAA4: Strong H-Bond acceptors_3 distribution of 1.00A,Hydrogen bond related,#6a3d9a
207,7,11,CNHB4: NH- count distribution of 1.00B,Molecular fingerprint,#8c8c8c
208,7,12,TPSA4: Topological polar surface area_3 distribution of 1.00A,Topological indice,#cab2d6
209,7,13,MLFB4: Linear free energy distribution of 1.00B,Hydrogen bond related,#6a3d9a
210,7,14,LFI: Lipoaffinity index100,Solubility lipoaffinity,#33a02c
211,7,15,DPRG4: Distribution of 1.00G,Transcript related,#fb9a99
212,7,16,CNHAB: NH- count transition between A and B,Molecular fingerprint,#8c8c8c
213,7,17,CNH: NH- count10,Molecular fingerprint,#8c8c8c
214,7,18,SHD: Strong H-Bond donors001,Hydrogen bond related,#6a3d9a
215,7,19,SLF: Sum of path lengths starting from oxygens_301,Topological indice,#cab2d6
216,7,20,LFI: Lipoaffinity index_3120,Solubility lipoaffinity,#33a02c
217,7,21,PCDAC: Parallel correlation PseDN composition of AC,Nucleotide related,#b2df8a
218,7,22,SHDAB: Strong H-Bond donors transition between A and B,Hydrogen bond related,#6a3d9a
219,7,23,TPSAC: Topological polar surface area_3 transition between A and C,Topological indice,#cab2d6
220,7,24,FickS: Fickett score,Codon related,#e31a1c
221,7,25,SHD: Strong H-Bond donors101,Hydrogen bond related,#6a3d9a
222,7,26,GCC3V: GCCo3 variance frame score,Guanine-cytosine related,#fdbf6f
223,7,27,GCC2V: GCCo2 variance frame score,Guanine-cytosine related,#fdbf6f
224,8,0,L1SLI: Series correlation PseDN composition of lamda1-SLI,Nucleotide related,#b2df8a
225,8,1,CC110: Cross covariance of lag1 on BDS-SLI,Nucleotide related,#b2df8a
226,8,2,CC227: Cross covariance of lag2 on SLI-BDS,Nucleotide related,#b2df8a
227,8,3,CC228: Cross covariance of lag2 on SLI-ETI,Nucleotide related,#b2df8a
228,8,4,ORFIn: ORF integrity,Open reading frame,#ff7f00
229,8,5,CNHB2: NH- count distribution of 0.50B,Molecular fingerprint,#8c8c8c
230,8,6,PSNB4: Primary or secondary nitrogens distribution of 1.00B,Topological indice,#cab2d6
231,8,7,TPSB4: Topological polar surface area_3 distribution of 1.00B,Topological indice,#cab2d6
232,8,8,MReB4: Molar refractivity distribution of 1.00B,Polarizability refractivity,#1f78b4
233,8,9,LFIA4: Lipoaffinity index distribution of 1.00A,Solubility lipoaffinity,#33a02c
234,8,10,LFIA4: Lipoaffinity index_3 distribution of 1.00A,Solubility lipoaffinity,#33a02c
235,8,11,PCDl2: Parallel correlation PseDN composition of lamda2,Nucleotide related,#b2df8a
236,8,12,LFI: Lipoaffinity index001,Solubility lipoaffinity,#33a02c
237,8,13,SLFA4: Sum of path lengths starting from oxygens_3 distribution of 1.00A,Topological indice,#cab2d6
238,8,14,TPSC4: Topological polar surface area_3 distriCution of 1.00C,Topological indice,#cab2d6
239,8,15,LFIC4: Lipoaffinity index_3 distriCution of 1.00C,Solubility lipoaffinity,#33a02c
240,8,16,CNH: NH- count01,Molecular fingerprint,#8c8c8c
241,8,17,TPS: Topological polar surface area_3201,Topological indice,#cab2d6
242,8,18,SHD: Strong H-Bond donors100,Hydrogen bond related,#6a3d9a
243,8,19,PSNCA: Primary or secondary nitrogens composition of A,Topological indice,#cab2d6
244,8,20,LFI: Lipoaffinity index_3012,Solubility lipoaffinity,#33a02c
245,8,21,SHD: Strong H-Bond donors010,Hydrogen bond related,#6a3d9a
246,8,22,TPS: Topological polar surface area_3200,Topological indice,#cab2d6
247,8,23,TPS: Topological polar surface area_3002,Topological indice,#cab2d6
248,8,24,SLF: Sum of path lengths starting from oxygens_3100,Topological indice,#cab2d6
249,8,25,LFI: Lipoaffinity index_3202,Solubility lipoaffinity,#33a02c
250,8,26,TraEW: Entropy density W on transcript,Transcript related,#fb9a99
251,8,27,SCDTC: Series correlation PseDN composition of TC,Nucleotide related,#b2df8a
252,9,0,APDT1: Dinucleotide auto covariance of lag1 on PDT,Nucleotide related,#b2df8a
253,9,1,ATIL1: Dinucleotide auto covariance of lag1 on TIL,Nucleotide related,#b2df8a
254,9,2,CC115: Cross covariance of lag1 on ETI-SLI,Nucleotide related,#b2df8a
255,9,3,CC230: Cross covariance of lag2 on SLI-WCI,Nucleotide related,#b2df8a
256,9,4,CC229: Cross covariance of lag2 on SLI-SKE,Nucleotide related,#b2df8a
257,9,5,SHA: Strong H-Bond acceptors_30,Hydrogen bond related,#6a3d9a
258,9,6,CNH: NH- count011,Molecular fingerprint,#8c8c8c
259,9,7,SLFC4: Sum of path lengths starting from oxygens_3 distriCution of 1.00C,Topological indice,#cab2d6
260,9,8,HPCC4: Gas-hexadecane PC_3 distriCution of 1.00C,Partition coefficient,#a6cee3
261,9,9,DPRT4: Distribution of 1.00T,Transcript related,#fb9a99
262,9,10,PCDl1: Parallel correlation PseDN composition of lamda1,Nucleotide related,#b2df8a
263,9,11,(((,Secondary structure,#666666
264,9,12,((((,Secondary structure,#666666
265,9,13,PHBC4: Potential Hydrogen Bonds_3 distriCution of 1.00C,Hydrogen bond related,#6a3d9a
266,9,14,PPMFS: Pseudo protein PI-MW frame score,Pseudo protein related,#ffed6f
267,9,15,SHDB4: Strong H-Bond donors distribution of 1.00B,Hydrogen bond related,#6a3d9a
268,9,16,CNH: NH- count101,Molecular fingerprint,#8c8c8c
269,9,17,CNH: NH- count010,Molecular fingerprint,#8c8c8c
270,9,18,PSN: Primary or secondary nitrogens0,Topological indice,#cab2d6
271,9,19,SLFAB: Sum of path lengths starting from oxygens_3 transition between A and B,Topological indice,#cab2d6
272,9,20,SLF: Sum of path lengths starting from oxygens_310,Topological indice,#cab2d6
273,9,21,.(.,Secondary structure,#666666
274,9,22,PSN: Primary or secondary nitrogens00,Topological indice,#cab2d6
275,9,23,PSN: Primary or secondary nitrogens000,Topological indice,#cab2d6
276,9,24,SLF: Sum of path lengths starting from oxygens_3001,Topological indice,#cab2d6
277,9,25,GCCo1: GC content of 1st position of codons,Guanine-cytosine related,#fdbf6f
278,9,26,PCDTC: Parallel correlation PseDN composition of TC,Nucleotide related,#b2df8a
279,9,27,SLF: Sum of path lengths starting from oxygens_3000,Topological indice,#cab2d6
280,10,0,ATWI1: Dinucleotide auto covariance of lag1 on TWI,Nucleotide related,#b2df8a
281,10,1,CC205: Cross covariance of lag2 on PID-SLI,Nucleotide related,#b2df8a
282,10,2,CC125: Cross covariance of lag1 on WCI-SLI,Nucleotide related,#b2df8a
283,10,3,ABDT2: Dinucleotide auto covariance of lag2 on BDT,Nucleotide related,#b2df8a
284,10,4,APID2: Dinucleotide auto covariance of lag2 on PID,Nucleotide related,#b2df8a
285,10,5,MRe: Molar refractivity01,Polarizability refractivity,#1f78b4
286,10,6,SHA: Strong H-Bond acceptors_300,Hydrogen bond related,#6a3d9a
287,10,7,SHACA: Strong H-Bond acceptors_3 composition of A,Hydrogen bond related,#6a3d9a
288,10,8,CNH: NH- count110,Molecular fingerprint,#8c8c8c
289,10,9,ORFEL: Entropy density L on ORF,Open reading frame,#ff7f00
290,10,10,((,Secondary structure,#666666
291,10,11,(,Secondary structure,#666666
292,10,12,ORFES: Entropy density S on ORF,Open reading frame,#ff7f00
293,10,13,HPCB4: Gas-hexadecane PC_3 distribution of 1.00B,Partition coefficient,#a6cee3
294,10,14,DPRC4: Distribution of 1.00C,Transcript related,#fb9a99
295,10,15,MLF: Linear free energy10,Hydrogen bond related,#6a3d9a
296,10,16,SHA: Strong H-Bond acceptors_3201,Hydrogen bond related,#6a3d9a
297,10,17,SHA: Strong H-Bond acceptors_3102,Hydrogen bond related,#6a3d9a
298,10,18,CNH: NH- count001,Molecular fingerprint,#8c8c8c
299,10,19,TraEQ: Entropy density Q on transcript,Transcript related,#fb9a99
300,10,20,ORFEQ: Entropy density Q on ORF,Open reading frame,#ff7f00
301,10,21,(.(,Secondary structure,#666666
302,10,22,ORFCo: ORF coverage,Open reading frame,#ff7f00
303,10,23,HPC: Gas-hexadecane PC_3001,Partition coefficient,#a6cee3
304,10,24,SLF: Sum of path lengths starting from oxygens_30,Topological indice,#cab2d6
305,10,25,MLF: Linear free energy011,Hydrogen bond related,#6a3d9a
306,10,26,MLF: Linear free energy110,Hydrogen bond related,#6a3d9a
307,10,27,TraGC: Transition between G and C,Transcript related,#fb9a99
308,11,0,ARIS1: Dinucleotide auto covariance of lag1 on RIS,Nucleotide related,#b2df8a
309,11,1,CC226: Cross covariance of lag2 on SLI-PID,Nucleotide related,#b2df8a
310,11,2,ASFB1: Dinucleotide auto covariance of lag1 on SFB,Nucleotide related,#b2df8a
311,11,3,ASHI2: Dinucleotide auto covariance of lag2 on SHI,Nucleotide related,#b2df8a
312,11,4,CC220: Cross covariance of lag2 on SKE-SLI,Nucleotide related,#b2df8a
313,11,5,LFI: Lipoaffinity index_3201,Solubility lipoaffinity,#33a02c
314,11,6,HPC: Gas-hexadecane PC_3201,Partition coefficient,#a6cee3
315,11,7,CNH: NH- count11,Molecular fingerprint,#8c8c8c
316,11,8,CNH: NH- count1,Molecular fingerprint,#8c8c8c
317,11,9,ProAH: Pseudo protein average hydropathy,Pseudo protein related,#ffed6f
318,11,10,MRe: Molar refractivity011,Polarizability refractivity,#1f78b4
319,11,11,MRe: Molar refractivity110,Polarizability refractivity,#1f78b4
320,11,12,PHBB4: Potential Hydrogen Bonds_3 distribution of 1.00B,Hydrogen bond related,#6a3d9a
321,11,13,HPCB4: Gas-hexadecane PC distribution of 1.00B,Partition coefficient,#a6cee3
322,11,14,SHAC4: Strong H-Bond acceptors_3 distriCution of 1.00C,Hydrogen bond related,#6a3d9a
323,11,15,MLF: Linear free energy01,Hydrogen bond related,#6a3d9a
324,11,16,HPC: Gas-hexadecane PC100,Partition coefficient,#a6cee3
325,11,17,SHA: Strong H-Bond acceptors_3210,Hydrogen bond related,#6a3d9a
326,11,18,CNH: NH- count100,Molecular fingerprint,#8c8c8c
327,11,19,TPSCA: Topological polar surface area_3 composition of A,Topological indice,#cab2d6
328,11,20,CNH: NH- count0,Molecular fingerprint,#8c8c8c
329,11,21,((.(,Secondary structure,#666666
330,11,22,HPC: Gas-hexadecane PC_3100,Partition coefficient,#a6cee3
331,11,23,SLF: Sum of path lengths starting from oxygens_3010,Topological indice,#cab2d6
332,11,24,MLF: Linear free energy1,Hydrogen bond related,#6a3d9a
333,11,25,GCCo2: GC content of 2nd position of codons,Guanine-cytosine related,#fdbf6f
334,11,26,PHB: Potential Hydrogen Bonds_3012,Hydrogen bond related,#6a3d9a
335,11,27,PHBBC: Potential Hydrogen Bonds_3 transition between B and C,Hydrogen bond related,#6a3d9a
336,12,0,ASEZ1: Dinucleotide auto covariance of lag1 on SEZ,Nucleotide related,#b2df8a
337,12,1,ALBZ1: Dinucleotide auto covariance of lag1 on LBZ,Nucleotide related,#b2df8a
338,12,2,ABDT1: Dinucleotide auto covariance of lag1 on BDT,Nucleotide related,#b2df8a
339,12,3,ASHI1: Dinucleotide auto covariance of lag1 on SHI,Nucleotide related,#b2df8a
340,12,4,L2PID: Series correlation PseDN composition of lamda2-PID,Nucleotide related,#b2df8a
341,12,5,ATWI2: Dinucleotide auto covariance of lag2 on TWI,Nucleotide related,#b2df8a
342,12,6,MReAB: Molar refractivity transition between A and B,Polarizability refractivity,#1f78b4
343,12,7,SHA: Strong H-Bond acceptors_3000,Hydrogen bond related,#6a3d9a
344,12,8,CNHCB: NH- count composition of B,Molecular fingerprint,#8c8c8c
345,12,9,ORFEV: Entropy density V on ORF,Open reading frame,#ff7f00
346,12,10,TraEL: Entropy density L on transcript,Transcript related,#fb9a99
347,12,11,TraES: Entropy density S on transcript,Transcript related,#fb9a99
348,12,12,MRe: Molar refractivity1,Polarizability refractivity,#1f78b4
349,12,13,LFI: Lipoaffinity index0,Solubility lipoaffinity,#33a02c
350,12,14,LFICA: Lipoaffinity index composition of A,Solubility lipoaffinity,#33a02c
351,12,15,MLFAB: Linear free energy transition between A and B,Hydrogen bond related,#6a3d9a
352,12,16,HPC: Gas-hexadecane PC001,Partition coefficient,#a6cee3
353,12,17,SHA: Strong H-Bond acceptors_3120,Hydrogen bond related,#6a3d9a
354,12,18,CNHCA: NH- count composition of A,Molecular fingerprint,#8c8c8c
355,12,19,TPS: Topological polar surface area_30,Topological indice,#cab2d6
356,12,20,TPS: Topological polar surface area_300,Topological indice,#cab2d6
357,12,21,(.((,Secondary structure,#666666
358,12,22,PHB: Potential Hydrogen Bonds_3201,Hydrogen bond related,#6a3d9a
359,12,23,MLF: Linear free energy101,Hydrogen bond related,#6a3d9a
360,12,24,GCCoW: GC content of whole sequence,Guanine-cytosine related,#fdbf6f
361,12,25,SLFCA: Sum of path lengths starting from oxygens_3 composition of A,Topological indice,#cab2d6
362,12,26,PHB: Potential Hydrogen Bonds_3120,Hydrogen bond related,#6a3d9a
363,12,27,SLF: Sum of path lengths starting from oxygens_300,Topological indice,#cab2d6
364,13,0,AHTF1: Dinucleotide auto covariance of lag1 on HTF,Nucleotide related,#b2df8a
365,13,1,CC216: Cross covariance of lag2 on SKE-PID,Nucleotide related,#b2df8a
366,13,2,ASDS2: Dinucleotide auto covariance of lag2 on SDS,Nucleotide related,#b2df8a
367,13,3,AABA2: Dinucleotide auto covariance of lag2 on ABA,Nucleotide related,#b2df8a
368,13,4,ATIL2: Dinucleotide auto covariance of lag2 on TIL,Nucleotide related,#b2df8a
369,13,5,ASLI2: Dinucleotide auto covariance of lag2 on SLI,Nucleotide related,#b2df8a
370,13,6,CC126: Cross covariance of lag1 on SLI-PID,Nucleotide related,#b2df8a
371,13,7,MRe: Molar refractivity10,Polarizability refractivity,#1f78b4
372,13,8,CNH: NH- count111,Molecular fingerprint,#8c8c8c
373,13,9,ORFEW: Entropy density W on ORF,Open reading frame,#ff7f00
374,13,10,LFICA: Lipoaffinity index_3 composition of A,Solubility lipoaffinity,#33a02c
375,13,11,MReCB: Molar refractivity composition of B,Polarizability refractivity,#1f78b4
376,13,12,LFI: Lipoaffinity index_30,Solubility lipoaffinity,#33a02c
377,13,13,MRe: Molar refractivity11,Polarizability refractivity,#1f78b4
378,13,14,SCDGT: Series correlation PseDN composition of GT,Nucleotide related,#b2df8a
379,13,15,PHBAB: Potential Hydrogen Bonds_3 transition between A and B,Hydrogen bond related,#6a3d9a
380,13,16,HPC: Gas-hexadecane PC010,Partition coefficient,#a6cee3
381,13,17,SCDTA: Series correlation PseDN composition of TA,Nucleotide related,#b2df8a
382,13,18,PCDTA: Parallel correlation PseDN composition of TA,Nucleotide related,#b2df8a
383,13,19,CNH: NH- count00,Molecular fingerprint,#8c8c8c
384,13,20,.(,Secondary structure,#666666
385,13,21,.((.,Secondary structure,#666666
386,13,22,HPC: Gas-hexadecane PC_3010,Partition coefficient,#a6cee3
387,13,23,MLFCB: Linear free energy composition of B,Hydrogen bond related,#6a3d9a
388,13,24,PHB: Potential Hydrogen Bonds_3210,Hydrogen bond related,#6a3d9a
389,13,25,GCCo3: GC content of 3rd position of codons,Guanine-cytosine related,#fdbf6f
390,13,26,PCDCT: Parallel correlation PseDN composition of CT,Nucleotide related,#b2df8a
391,13,27,MLF: Linear free energy111,Hydrogen bond related,#6a3d9a
392,14,0,CC203: Cross covariance of lag2 on PID-SKE,Nucleotide related,#b2df8a
393,14,1,APID1: Dinucleotide auto covariance of lag1 on PID,Nucleotide related,#b2df8a
394,14,2,ASDH2: Dinucleotide auto covariance of lag2 on SDH,Nucleotide related,#b2df8a
395,14,3,ASFB2: Dinucleotide auto covariance of lag2 on SFB,Nucleotide related,#b2df8a
396,14,4,AAPH2: Dinucleotide auto covariance of lag2 on APH,Nucleotide related,#b2df8a
397,14,5,APDT2: Dinucleotide auto covariance of lag2 on PDT,Nucleotide related,#b2df8a
398,14,6,ASEZ2: Dinucleotide auto covariance of lag2 on SEZ,Nucleotide related,#b2df8a
399,14,7,CC105: Cross covariance of lag1 on PID-SLI,Nucleotide related,#b2df8a
400,14,8,TPS: Topological polar surface area_3021,Topological indice,#cab2d6
401,14,9,TraEC: Entropy density C on transcript,Transcript related,#fb9a99
402,14,10,TPS: Topological polar surface area_3012,Topological indice,#cab2d6
403,14,11,SLF: Sum of path lengths starting from oxygens_302,Topological indice,#cab2d6
404,14,12,MRe: Molar refractivity111,Polarizability refractivity,#1f78b4
405,14,13,LFI: Lipoaffinity index_300,Solubility lipoaffinity,#33a02c
406,14,14,PCDGT: Parallel correlation PseDN composition of GT,Nucleotide related,#b2df8a
407,14,15,PHB: Potential Hydrogen Bonds_310,Hydrogen bond related,#6a3d9a
408,14,16,SHA: Strong H-Bond acceptors_3021,Hydrogen bond related,#6a3d9a
409,14,17,SHA: Strong H-Bond acceptors_3012,Hydrogen bond related,#6a3d9a
410,14,18,SHABC: Strong H-Bond acceptors_3 transition between B and C,Hydrogen bond related,#6a3d9a
411,14,19,TPS: Topological polar surface area_3000,Topological indice,#cab2d6
412,14,20,.((,Secondary structure,#666666
413,14,21,(.,Secondary structure,#666666
414,14,22,HPC: Gas-hexadecane PC_310,Partition coefficient,#a6cee3
415,14,23,LFIAC: Lipoaffinity index_3 transition between A and C,Solubility lipoaffinity,#33a02c
416,14,24,PHB: Potential Hydrogen Bonds_3102,Hydrogen bond related,#6a3d9a
417,14,25,TraEA: Entropy density A on transcript,Transcript related,#fb9a99
418,14,26,SCDCT: Series correlation PseDN composition of CT,Nucleotide related,#b2df8a
419,14,27,MLF: Linear free energy11,Hydrogen bond related,#6a3d9a
420,15,0,L1PID: Series correlation PseDN composition of lamda1-PID,Nucleotide related,#b2df8a
421,15,1,AAPH1: Dinucleotide auto covariance of lag1 on APH,Nucleotide related,#b2df8a
422,15,2,AIBA1: Dinucleotide auto covariance of lag1 on IBA,Nucleotide related,#b2df8a
423,15,3,AABA1: Dinucleotide auto covariance of lag1 on ABA,Nucleotide related,#b2df8a
424,15,4,AROL2: Dinucleotide auto covariance of lag2 on ROL,Nucleotide related,#b2df8a
425,15,5,AIBA2: Dinucleotide auto covariance of lag2 on IBA,Nucleotide related,#b2df8a
426,15,6,ARIS2: Dinucleotide auto covariance of lag2 on RIS,Nucleotide related,#b2df8a
427,15,7,MRe: Molar refractivity101,Polarizability refractivity,#1f78b4
428,15,8,TraEV: Entropy density V on transcript,Transcript related,#fb9a99
429,15,9,TPSBC: Topological polar surface area_3 transition between B and C,Topological indice,#cab2d6
430,15,10,SCDGC: Series correlation PseDN composition of GC,Nucleotide related,#b2df8a
431,15,11,SLFAC: Sum of path lengths starting from oxygens_3 transition between A and C,Topological indice,#cab2d6
432,15,12,LFI: Lipoaffinity index_3000,Solubility lipoaffinity,#33a02c
433,15,13,TraTC: Transition between T and C,Transcript related,#fb9a99
434,15,14,HPCBC: Gas-hexadecane PC_3 transition between B and C,Partition coefficient,#a6cee3
435,15,15,HPC: Gas-hexadecane PC_3021,Partition coefficient,#a6cee3
436,15,16,PHB: Potential Hydrogen Bonds_301,Hydrogen bond related,#6a3d9a
437,15,17,TraAC: Transition between A and C,Transcript related,#fb9a99
438,15,18,PCDAT: Parallel correlation PseDN composition of AT,Nucleotide related,#b2df8a
439,15,19,CNH: NH- count000,Molecular fingerprint,#8c8c8c
440,15,20,.(((,Secondary structure,#666666
441,15,21,((.,Secondary structure,#666666
442,15,22,HPCAB: Gas-hexadecane PC_3 transition between A and B,Partition coefficient,#a6cee3
443,15,23,LFI: Lipoaffinity index_320,Solubility lipoaffinity,#33a02c
444,15,24,HPC: Gas-hexadecane PC_301,Partition coefficient,#a6cee3
445,15,25,PHB: Potential Hydrogen Bonds_3021,Hydrogen bond related,#6a3d9a
446,15,26,SLF: Sum of path lengths starting from oxygens_3200,Topological indice,#cab2d6
447,15,27,HPC: Gas-hexadecane PC_3110,Partition coefficient,#a6cee3
448,16,0,ADDT1: Dinucleotide auto covariance of lag1 on DDT,Nucleotide related,#b2df8a
449,16,1,CC206: Cross covariance of lag2 on BDS-PID,Nucleotide related,#b2df8a
450,16,2,ABDH2: Dinucleotide auto covariance of lag2 on BDH,Nucleotide related,#b2df8a
451,16,3,ABLS2: Dinucleotide auto covariance of lag2 on BLS,Nucleotide related,#b2df8a
452,16,4,ASDS1: Dinucleotide auto covariance of lag1 on SDS,Nucleotide related,#b2df8a
453,16,5,L2SLI: Series correlation PseDN composition of lamda2-SLI,Nucleotide related,#b2df8a
454,16,6,ALBZ2: Dinucleotide auto covariance of lag2 on LBZ,Nucleotide related,#b2df8a
455,16,7,MRe: Molar refractivity010,Polarizability refractivity,#1f78b4
456,16,8,SCDCG: Series correlation PseDN composition of CG,Nucleotide related,#b2df8a
457,16,9,TraTG: Transition between T and G,Transcript related,#fb9a99
458,16,10,PCDGC: Parallel correlation PseDN composition of GC,Nucleotide related,#b2df8a
459,16,11,TPS: Topological polar surface area_3120,Topological indice,#cab2d6
460,16,12,SLF: Sum of path lengths starting from oxygens_320,Topological indice,#cab2d6
461,16,13,PCDTG: Parallel correlation PseDN composition of TG,Nucleotide related,#b2df8a
462,16,14,SCDTG: Series correlation PseDN composition of TG,Nucleotide related,#b2df8a
463,16,15,HPC: Gas-hexadecane PC_3012,Partition coefficient,#a6cee3
464,16,16,HPC: Gas-hexadecane PC_3210,Partition coefficient,#a6cee3
465,16,17,TraEH: Entropy density H on transcript,Transcript related,#fb9a99
466,16,18,TraET: Entropy density T on transcript,Transcript related,#fb9a99
467,16,19,ORFET: Entropy density T on ORF,Open reading frame,#ff7f00
468,16,20,((..,Secondary structure,#666666
469,16,21,..((,Secondary structure,#666666
470,16,22,(((.,Secondary structure,#666666
471,16,23,LFI: Lipoaffinity index_302,Solubility lipoaffinity,#33a02c
472,16,24,SLF: Sum of path lengths starting from oxygens_3020,Topological indice,#cab2d6
473,16,25,SLF: Sum of path lengths starting from oxygens_3002,Topological indice,#cab2d6
474,16,26,HPC: Gas-hexadecane PC_3011,Partition coefficient,#a6cee3
475,16,27,SHA: Strong H-Bond acceptors_3220,Hydrogen bond related,#6a3d9a
476,17,0,CC221: Cross covariance of lag2 on WCI-PID,Nucleotide related,#b2df8a
477,17,1,CC211: Cross covariance of lag2 on ETI-PID,Nucleotide related,#b2df8a
478,17,2,CC102: Cross covariance of lag1 on PID-ETI,Nucleotide related,#b2df8a
479,17,3,CC106: Cross covariance of lag1 on BDS-PID,Nucleotide related,#b2df8a
480,17,4,CC103: Cross covariance of lag1 on PID-SKE,Nucleotide related,#b2df8a
481,17,5,ASDH1: Dinucleotide auto covariance of lag1 on SDH,Nucleotide related,#b2df8a
482,17,6,ASTB2: Dinucleotide auto covariance of lag2 on STB,Nucleotide related,#b2df8a
483,17,7,AHTF2: Dinucleotide auto covariance of lag2 on HTF,Nucleotide related,#b2df8a
484,17,8,HPC: Gas-hexadecane PC_3102,Partition coefficient,#a6cee3
485,17,9,PCDCG: Parallel correlation PseDN composition of CG,Nucleotide related,#b2df8a
486,17,10,ORFEC: Entropy density C on ORF,Open reading frame,#ff7f00
487,17,11,PSN: Primary or secondary nitrogens001,Topological indice,#cab2d6
488,17,12,PSN: Primary or secondary nitrogens100,Topological indice,#cab2d6
489,17,13,ORFEM: Entropy density M on ORF,Open reading frame,#ff7f00
490,17,14,HPC: Gas-hexadecane PC_3120,Partition coefficient,#a6cee3
491,17,15,SHDCA: Strong H-Bond donors composition of A,Hydrogen bond related,#6a3d9a
492,17,16,HPCCA: Gas-hexadecane PC composition of A,Partition coefficient,#a6cee3
493,17,17,ORFEH: Entropy density H on ORF,Open reading frame,#ff7f00
494,17,18,SCDAT: Series correlation PseDN composition of AT,Nucleotide related,#b2df8a
495,17,19,(...,Secondary structure,#666666
496,17,20,(..,Secondary structure,#666666
497,17,21,..(,Secondary structure,#666666
498,17,22,HPC: Gas-hexadecane PC10,Partition coefficient,#a6cee3
499,17,23,LFI: Lipoaffinity index_3020,Solubility lipoaffinity,#33a02c
500,17,24,LFI: Lipoaffinity index_3200,Solubility lipoaffinity,#33a02c
501,17,25,HPC: Gas-hexadecane PC_3101,Partition coefficient,#a6cee3
502,17,26,PHB: Potential Hydrogen Bonds_3011,Hydrogen bond related,#6a3d9a
503,17,27,SHA: Strong H-Bond acceptors_3022,Hydrogen bond related,#6a3d9a
504,18,0,CC201: Cross covariance of lag2 on PID-BDS,Nucleotide related,#b2df8a
505,18,1,ADTB2: Dinucleotide auto covariance of lag2 on DTB,Nucleotide related,#b2df8a
506,18,2,CC101: Cross covariance of lag1 on PID-BDS,Nucleotide related,#b2df8a
507,18,3,CC104: Cross covariance of lag1 on PID-WCI,Nucleotide related,#b2df8a
508,18,4,ASMS2: Dinucleotide auto covariance of lag2 on SMS,Nucleotide related,#b2df8a
509,18,5,CC121: Cross covariance of lag1 on WCI-PID,Nucleotide related,#b2df8a
510,18,6,CC116: Cross covariance of lag1 on SKE-PID,Nucleotide related,#b2df8a
511,18,7,ADDT2: Dinucleotide auto covariance of lag2 on DDT,Nucleotide related,#b2df8a
512,18,8,LFI: Lipoaffinity index_3102,Solubility lipoaffinity,#33a02c
513,18,9,TPS: Topological polar surface area_3210,Topological indice,#cab2d6
514,18,10,PSN: Primary or secondary nitrogens010,Topological indice,#cab2d6
515,18,11,PSN: Primary or secondary nitrogens10,Topological indice,#cab2d6
516,18,12,TPS: Topological polar surface area_3100,Topological indice,#cab2d6
517,18,13,SHD: Strong H-Bond donors00,Hydrogen bond related,#6a3d9a
518,18,14,SHD: Strong H-Bond donors0,Hydrogen bond related,#6a3d9a
519,18,15,HPC: Gas-hexadecane PC0,Partition coefficient,#a6cee3
520,18,16,SLF: Sum of path lengths starting from oxygens_3201,Topological indice,#cab2d6
521,18,17,LFI: Lipoaffinity index10,Solubility lipoaffinity,#33a02c
522,18,18,LFI: Lipoaffinity index010,Solubility lipoaffinity,#33a02c
523,18,19,.,Secondary structure,#666666
524,18,20,..,Secondary structure,#666666
525,18,21,...(,Secondary structure,#666666
526,18,22,(..(,Secondary structure,#666666
527,18,23,HPC: Gas-hexadecane PC01,Partition coefficient,#a6cee3
528,18,24,SHA: Strong H-Bond acceptors_302,Hydrogen bond related,#6a3d9a
529,18,25,SHA: Strong H-Bond acceptors_3202,Hydrogen bond related,#6a3d9a
530,18,26,SHACC: Strong H-Bond acceptors_3 composition of C,Hydrogen bond related,#6a3d9a
531,18,27,HPC: Gas-hexadecane PC011,Partition coefficient,#a6cee3
532,19,0,CC204: Cross covariance of lag2 on PID-WCI,Nucleotide related,#b2df8a
533,19,1,ABDG2: Dinucleotide auto covariance of lag2 on BDG,Nucleotide related,#b2df8a
534,19,2,AHCT2: Dinucleotide auto covariance of lag2 on HCT,Nucleotide related,#b2df8a
535,19,3,L2ETI: Series correlation PseDN composition of lamda2-ETI,Nucleotide related,#b2df8a
536,19,4,ASMH2: Dinucleotide auto covariance of lag2 on SMH,Nucleotide related,#b2df8a
537,19,5,ABDS2: Dinucleotide auto covariance of lag2 on BDS,Nucleotide related,#b2df8a
538,19,6,CC111: Cross covariance of lag1 on ETI-PID,Nucleotide related,#b2df8a
539,19,7,ABST2: Dinucleotide auto covariance of lag2 on BST,Nucleotide related,#b2df8a
540,19,8,ASKE2: Dinucleotide auto covariance of lag2 on SKE,Nucleotide related,#b2df8a
541,19,9,PSNAB: Primary or secondary nitrogens transition between A and B,Topological indice,#cab2d6
542,19,10,PSN: Primary or secondary nitrogens01,Topological indice,#cab2d6
543,19,11,TPS: Topological polar surface area_301,Topological indice,#cab2d6
544,19,12,TPS: Topological polar surface area_3001,Topological indice,#cab2d6
545,19,13,LFI: Lipoaffinity index_3001,Solubility lipoaffinity,#33a02c
546,19,14,PHB: Potential Hydrogen Bonds_3010,Hydrogen bond related,#6a3d9a
547,19,15,SLF: Sum of path lengths starting from oxygens_3102,Topological indice,#cab2d6
548,19,16,MLF: Linear free energy010,Hydrogen bond related,#6a3d9a
549,19,17,HPC: Gas-hexadecane PC00,Partition coefficient,#a6cee3
550,19,18,PHB: Potential Hydrogen Bonds_3020,Hydrogen bond related,#6a3d9a
551,19,19,LFIAB: Lipoaffinity index transition between A and B,Solubility lipoaffinity,#33a02c
552,19,20,LFI: Lipoaffinity index01,Solubility lipoaffinity,#33a02c
553,19,21,...,Secondary structure,#666666
554,19,22,HPCAB: Gas-hexadecane PC transition between A and B,Partition coefficient,#a6cee3
555,19,23,LFI: Lipoaffinity index_3002,Solubility lipoaffinity,#33a02c
556,19,24,SHA: Strong H-Bond acceptors_3020,Hydrogen bond related,#6a3d9a
557,19,25,HPC: Gas-hexadecane PC101,Partition coefficient,#a6cee3
558,19,26,PHBCB: Potential Hydrogen Bonds_3 composition of B,Hydrogen bond related,#6a3d9a
559,19,27,HPC: Gas-hexadecane PC110,Partition coefficient,#a6cee3
560,20,0,ABLS1: Dinucleotide auto covariance of lag1 on BLS,Nucleotide related,#b2df8a
561,20,1,CC202: Cross covariance of lag2 on PID-ETI,Nucleotide related,#b2df8a
562,20,2,L2BDS: Series correlation PseDN composition of lamda2-BDS,Nucleotide related,#b2df8a
563,20,3,L2WCI: Series correlation PseDN composition of lamda2-WCI,Nucleotide related,#b2df8a
564,20,4,CC209: Cross covariance of lag2 on BDS-WCI,Nucleotide related,#b2df8a
565,20,5,CC222: Cross covariance of lag2 on WCI-BDS,Nucleotide related,#b2df8a
566,20,6,CC207: Cross covariance of lag2 on BDS-ETI,Nucleotide related,#b2df8a
567,20,7,L2SKE: Series correlation PseDN composition of lamda2-SKE,Nucleotide related,#b2df8a
568,20,8,nMFE,Secondary structure,#666666
569,20,9,SLF: Sum of path lengths starting from oxygens_3202,Topological indice,#cab2d6
570,20,10,TPS: Topological polar surface area_3010,Topological indice,#cab2d6
571,20,11,TPSAB: Topological polar surface area_3 transition between A and B,Topological indice,#cab2d6
572,20,12,LFI: Lipoaffinity index_3010,Solubility lipoaffinity,#33a02c
573,20,13,SHD: Strong H-Bond donors000,Hydrogen bond related,#6a3d9a
574,20,14,LFI: Lipoaffinity index_301,Solubility lipoaffinity,#33a02c
575,20,15,PHB: Potential Hydrogen Bonds_3001,Hydrogen bond related,#6a3d9a
576,20,16,HPC: Gas-hexadecane PC_3200,Partition coefficient,#a6cee3
577,20,17,SHA: Strong H-Bond acceptors_3100,Hydrogen bond related,#6a3d9a
578,20,18,SHA: Strong H-Bond acceptors_3001,Hydrogen bond related,#6a3d9a
579,20,19,SHA: Strong H-Bond acceptors_301,Hydrogen bond related,#6a3d9a
580,20,20,SHA: Strong H-Bond acceptors_3010,Hydrogen bond related,#6a3d9a
581,20,21,SHA: Strong H-Bond acceptors_310,Hydrogen bond related,#6a3d9a
582,20,22,....,Secondary structure,#666666
583,20,23,LFI: Lipoaffinity index000,Solubility lipoaffinity,#33a02c
584,20,24,SHAAC: Strong H-Bond acceptors_3 transition between A and C,Hydrogen bond related,#6a3d9a
585,20,25,HPCCB: Gas-hexadecane PC_3 composition of B,Partition coefficient,#a6cee3
586,20,26,ComRC: Composition of C,Transcript related,#fb9a99
587,20,27,SCDTT: Series correlation PseDN composition of TT,Nucleotide related,#b2df8a
588,21,0,ORFEA: Entropy density A on ORF,Open reading frame,#ff7f00
589,21,1,ABDH1: Dinucleotide auto covariance of lag1 on BDH,Nucleotide related,#b2df8a
590,21,2,ASMG2: Dinucleotide auto covariance of lag2 on SMG,Nucleotide related,#b2df8a
591,21,3,ADST2: Dinucleotide auto covariance of lag2 on DST,Nucleotide related,#b2df8a
592,21,4,CC212: Cross covariance of lag2 on ETI-BDS,Nucleotide related,#b2df8a
593,21,5,APTW2: Dinucleotide auto covariance of lag2 on PTW,Nucleotide related,#b2df8a
594,21,6,CC213: Cross covariance of lag2 on ETI-SKE,Nucleotide related,#b2df8a
595,21,7,L1SKE: Series correlation PseDN composition of lamda1-SKE,Nucleotide related,#b2df8a
596,21,8,ASTB1: Dinucleotide auto covariance of lag1 on STB,Nucleotide related,#b2df8a
597,21,9,ORFEF: Entropy density F on ORF,Open reading frame,#ff7f00
598,21,10,PSN: Primary or secondary nitrogens101,Topological indice,#cab2d6
599,21,11,TPS: Topological polar surface area_310,Topological indice,#cab2d6
600,21,12,ORFEY: Entropy density Y on ORF,Open reading frame,#ff7f00
601,21,13,LFI: Lipoaffinity index_3100,Solubility lipoaffinity,#33a02c
602,21,14,LFIAB: Lipoaffinity index_3 transition between A and B,Solubility lipoaffinity,#33a02c
603,21,15,PHB: Potential Hydrogen Bonds_3100,Hydrogen bond related,#6a3d9a
604,21,16,MLFCA: Linear free energy composition of A,Hydrogen bond related,#6a3d9a
605,21,17,MLF: Linear free energy0,Hydrogen bond related,#6a3d9a
606,21,18,PHB: Potential Hydrogen Bonds_30,Hydrogen bond related,#6a3d9a
607,21,19,SHAAB: Strong H-Bond acceptors_3 transition between A and B,Hydrogen bond related,#6a3d9a
608,21,20,SHA: Strong H-Bond acceptors_3101,Hydrogen bond related,#6a3d9a
609,21,21,LFI: Lipoaffinity index101,Solubility lipoaffinity,#33a02c
610,21,22,SLF: Sum of path lengths starting from oxygens_3101,Topological indice,#cab2d6
611,21,23,LFI: Lipoaffinity index00,Solubility lipoaffinity,#33a02c
612,21,24,SHA: Strong H-Bond acceptors_3002,Hydrogen bond related,#6a3d9a
613,21,25,PHB: Potential Hydrogen Bonds_3101,Hydrogen bond related,#6a3d9a
614,21,26,HPCCB: Gas-hexadecane PC composition of B,Partition coefficient,#a6cee3
615,21,27,PHB: Potential Hydrogen Bonds_3110,Hydrogen bond related,#6a3d9a
616,22,0,ADTB1: Dinucleotide auto covariance of lag1 on DTB,Nucleotide related,#b2df8a
617,22,1,ASMS1: Dinucleotide auto covariance of lag1 on SMS,Nucleotide related,#b2df8a
618,22,2,APIA2: Dinucleotide auto covariance of lag2 on PIA,Nucleotide related,#b2df8a
619,22,3,CC217: Cross covariance of lag2 on SKE-BDS,Nucleotide related,#b2df8a
620,22,4,CC214: Cross covariance of lag2 on ETI-WCI,Nucleotide related,#b2df8a
621,22,5,AWCI2: Dinucleotide auto covariance of lag2 on WCI,Nucleotide related,#b2df8a
622,22,6,CC208: Cross covariance of lag2 on BDS-SKE,Nucleotide related,#b2df8a
623,22,7,ASKE1: Dinucleotide auto covariance of lag1 on SKE,Nucleotide related,#b2df8a
624,22,8,AROL1: Dinucleotide auto covariance of lag1 on ROL,Nucleotide related,#b2df8a
625,22,9,PSNCB: Primary or secondary nitrogens composition of B,Topological indice,#cab2d6
626,22,10,TPSCB: Topological polar surface area_3 composition of B,Topological indice,#cab2d6
627,22,11,TPS: Topological polar surface area_3101,Topological indice,#cab2d6
628,22,12,HPC: Gas-hexadecane PC_320,Partition coefficient,#a6cee3
629,22,13,ORFEI: Entropy density I on ORF,Open reading frame,#ff7f00
630,22,14,LFI: Lipoaffinity index_310,Solubility lipoaffinity,#33a02c
631,22,15,TraEM: Entropy density M on transcript,Transcript related,#fb9a99
632,22,16,PHBCA: Potential Hydrogen Bonds_3 composition of A,Hydrogen bond related,#6a3d9a
633,22,17,HPC: Gas-hexadecane PC_3002,Partition coefficient,#a6cee3
634,22,18,HPC: Gas-hexadecane PC000,Partition coefficient,#a6cee3
635,22,19,ComRA: Composition of A,Transcript related,#fb9a99
636,22,20,SLFCB: Sum of path lengths starting from oxygens_3 composition of B,Topological indice,#cab2d6
637,22,21,SHACB: Strong H-Bond acceptors_3 composition of B,Hydrogen bond related,#6a3d9a
638,22,22,ORFEN: Entropy density N on ORF,Open reading frame,#ff7f00
639,22,23,ORFEK: Entropy density K on ORF,Open reading frame,#ff7f00
640,22,24,SHA: Strong H-Bond acceptors_3200,Hydrogen bond related,#6a3d9a
641,22,25,SHA: Strong H-Bond acceptors_320,Hydrogen bond related,#6a3d9a
642,22,26,ORFEP: Entropy density P on ORF,Open reading frame,#ff7f00
643,22,27,PCDTT: Parallel correlation PseDN composition of TT,Nucleotide related,#b2df8a
644,23,0,ABDG1: Dinucleotide auto covariance of lag1 on BDG,Nucleotide related,#b2df8a
645,23,1,ASMH1: Dinucleotide auto covariance of lag1 on SMH,Nucleotide related,#b2df8a
646,23,2,L1BDS: Series correlation PseDN composition of lamda1-BDS,Nucleotide related,#b2df8a
647,23,3,ASDG2: Dinucleotide auto covariance of lag2 on SDG,Nucleotide related,#b2df8a
648,23,4,AETI2: Dinucleotide auto covariance of lag2 on ETI,Nucleotide related,#b2df8a
649,23,5,CC219: Cross covariance of lag2 on SKE-WCI,Nucleotide related,#b2df8a
650,23,6,CC218: Cross covariance of lag2 on SKE-ETI,Nucleotide related,#b2df8a
651,23,7,CC224: Cross covariance of lag2 on WCI-SKE,Nucleotide related,#b2df8a
652,23,8,ABST1: Dinucleotide auto covariance of lag1 on BST,Nucleotide related,#b2df8a
653,23,9,ComRT: Composition of T,Transcript related,#fb9a99
654,23,10,HPCCC: Gas-hexadecane PC_3 composition of C,Partition coefficient,#a6cee3
655,23,11,SLFCC: Sum of path lengths starting from oxygens_3 composition of C,Topological indice,#cab2d6
656,23,12,HPCAC: Gas-hexadecane PC_3 transition between A and C,Partition coefficient,#a6cee3
657,23,13,HPC: Gas-hexadecane PC_3020,Partition coefficient,#a6cee3
658,23,14,HPC: Gas-hexadecane PC_302,Partition coefficient,#a6cee3
659,23,15,SLF: Sum of path lengths starting from oxygens_3120,Topological indice,#cab2d6
660,23,16,SLF: Sum of path lengths starting from oxygens_3012,Topological indice,#cab2d6
661,23,17,MLF: Linear free energy001,Hydrogen bond related,#6a3d9a
662,23,18,PHB: Potential Hydrogen Bonds_3002,Hydrogen bond related,#6a3d9a
663,23,19,PHB: Potential Hydrogen Bonds_3200,Hydrogen bond related,#6a3d9a
664,23,20,LFICB: Lipoaffinity index composition of B,Solubility lipoaffinity,#33a02c
665,23,21,LFICB: Lipoaffinity index_3 composition of B,Solubility lipoaffinity,#33a02c
666,23,22,SLF: Sum of path lengths starting from oxygens_3110,Topological indice,#cab2d6
667,23,23,SCFFS: Stop codon frequency frame score,Codon related,#e31a1c
668,23,24,LORFL: Longest ORF length,Open reading frame,#ff7f00
669,23,25,ProMW: Pseudo protein molecular weight,Pseudo protein related,#ffed6f
670,23,26,EiPS2: Electron-ion interaction pseudopotential spectrum 0.5,EIIP based spectrum,#ffffb3
671,23,27,TraEP: Entropy density P on transcript,Transcript related,#fb9a99
672,24,0,AHCT1: Dinucleotide auto covariance of lag1 on HCT,Nucleotide related,#b2df8a
673,24,1,ABDS1: Dinucleotide auto covariance of lag1 on BDS,Nucleotide related,#b2df8a
674,24,2,CC112: Cross covariance of lag1 on ETI-BDS,Nucleotide related,#b2df8a
675,24,3,ASMG1: Dinucleotide auto covariance of lag1 on SMG,Nucleotide related,#b2df8a
676,24,4,CC109: Cross covariance of lag1 on BDS-WCI,Nucleotide related,#b2df8a
677,24,5,ADGC2: Dinucleotide auto covariance of lag2 on DGC,Nucleotide related,#b2df8a
678,24,6,CC223: Cross covariance of lag2 on WCI-ETI,Nucleotide related,#b2df8a
679,24,7,CC108: Cross covariance of lag1 on BDS-SKE,Nucleotide related,#b2df8a
680,24,8,CC124: Cross covariance of lag1 on WCI-SKE,Nucleotide related,#b2df8a
681,24,9,C3UTR: Coverage of 3 untranslated region,Transcript related,#fb9a99
682,24,10,SLF: Sum of path lengths starting from oxygens_3220,Topological indice,#cab2d6
683,24,11,SLF: Sum of path lengths starting from oxygens_3022,Topological indice,#cab2d6
684,24,12,HPC: Gas-hexadecane PC_3202,Partition coefficient,#a6cee3
685,24,13,SLF: Sum of path lengths starting from oxygens_3021,Topological indice,#cab2d6
686,24,14,SLF: Sum of path lengths starting from oxygens_3210,Topological indice,#cab2d6
687,24,15,SCDAG: Series correlation PseDN composition of AG,Nucleotide related,#b2df8a
688,24,16,TraEI: Entropy density I on transcript,Transcript related,#fb9a99
689,24,17,LFI: Lipoaffinity index_3101,Solubility lipoaffinity,#33a02c
690,24,18,MLF: Linear free energy100,Hydrogen bond related,#6a3d9a
691,24,19,LFI: Lipoaffinity index110,Solubility lipoaffinity,#33a02c
692,24,20,SLF: Sum of path lengths starting from oxygens_3011,Topological indice,#cab2d6
693,24,21,SHA: Strong H-Bond acceptors_3110,Hydrogen bond related,#6a3d9a
694,24,22,TraEK: Entropy density K on transcript,Transcript related,#fb9a99
695,24,23,EiSNR: Electron-ion interaction pseudopotential signal/noise ratio,EIIP based spectrum,#ffffb3
696,24,24,EipSP: Electron-ion interaction pseudopotential signal peak,EIIP based spectrum,#ffffb3
697,24,25,EiPS1: Electron-ion interaction pseudopotential spectrum 0.25,EIIP based spectrum,#ffffb3
698,24,26,EiPS0: Electron-ion interaction pseudopotential spectrum 0,EIIP based spectrum,#ffffb3
699,24,27,0,NaN,#000000
700,25,0,ADST1: Dinucleotide auto covariance of lag1 on DST,Nucleotide related,#b2df8a
701,25,1,APTW1: Dinucleotide auto covariance of lag1 on PTW,Nucleotide related,#b2df8a
702,25,2,AETI1: Dinucleotide auto covariance of lag1 on ETI,Nucleotide related,#b2df8a
703,25,3,CC122: Cross covariance of lag1 on WCI-BDS,Nucleotide related,#b2df8a
704,25,4,CC107: Cross covariance of lag1 on BDS-ETI,Nucleotide related,#b2df8a
705,25,5,ASDG1: Dinucleotide auto covariance of lag1 on SDG,Nucleotide related,#b2df8a
706,25,6,CC117: Cross covariance of lag1 on SKE-BDS,Nucleotide related,#b2df8a
707,25,7,TPS: Topological polar surface area_3102,Topological indice,#cab2d6
708,25,8,CC113: Cross covariance of lag1 on ETI-SKE,Nucleotide related,#b2df8a
709,25,9,TraEF: Entropy density F on transcript,Transcript related,#fb9a99
710,25,10,TPS: Topological polar surface area_3110,Topological indice,#cab2d6
711,25,11,PSN: Primary or secondary nitrogens110,Topological indice,#cab2d6
712,25,12,PSN: Primary or secondary nitrogens011,Topological indice,#cab2d6
713,25,13,SCDGA: Series correlation PseDN composition of GA,Nucleotide related,#b2df8a
714,25,14,TraEY: Entropy density Y on transcript,Transcript related,#fb9a99
715,25,15,PCDGA: Parallel correlation PseDN composition of GA,Nucleotide related,#b2df8a
716,25,16,SLFBC: Sum of path lengths starting from oxygens_3 transition between B and C,Topological indice,#cab2d6
717,25,17,PCDAG: Parallel correlation PseDN composition of AG,Nucleotide related,#b2df8a
718,25,18,TraEN: Entropy density N on transcript,Transcript related,#fb9a99
719,25,19,LFI: Lipoaffinity index_3110,Solubility lipoaffinity,#33a02c
720,25,20,SCDAA: Series correlation PseDN composition of AA,Nucleotide related,#b2df8a
721,25,21,SHA: Strong H-Bond acceptors_3011,Hydrogen bond related,#6a3d9a
722,25,22,SCCFS: Stop codon count frame score,Codon related,#e31a1c
723,25,23,EiPS4: Electron-ion interaction pseudopotential spectrum 1,EIIP based spectrum,#ffffb3
724,25,24,SCFre: Stop codon frequency,Codon related,#e31a1c
725,25,25,EiPS3: Electron-ion interaction pseudopotential spectrum 0.75,EIIP based spectrum,#ffffb3
726,25,26,TrLen: Transcript length,Transcript related,#fb9a99
727,25,27,0,NaN,#000000
728,26,0,L1WCI: Series correlation PseDN composition of lamda1-WCI,Nucleotide related,#b2df8a
729,26,1,L1ETI: Series correlation PseDN composition of lamda1-ETI,Nucleotide related,#b2df8a
730,26,2,AWCI1: Dinucleotide auto covariance of lag1 on WCI,Nucleotide related,#b2df8a
731,26,3,APIA1: Dinucleotide auto covariance of lag1 on PIA,Nucleotide related,#b2df8a
732,26,4,CC114: Cross covariance of lag1 on ETI-WCI,Nucleotide related,#b2df8a
733,26,5,ADGC1: Dinucleotide auto covariance of lag1 on DGC,Nucleotide related,#b2df8a
734,26,6,CC123: Cross covariance of lag1 on WCI-ETI,Nucleotide related,#b2df8a
735,26,7,CC119: Cross covariance of lag1 on SKE-WCI,Nucleotide related,#b2df8a
736,26,8,CC118: Cross covariance of lag1 on SKE-ETI,Nucleotide related,#b2df8a
737,26,9,SCDGG: Series correlation PseDN composition of GG,Nucleotide related,#b2df8a
738,26,10,TPS: Topological polar surface area_3011,Topological indice,#cab2d6
739,26,11,PCDGG: Parallel correlation PseDN composition of GG,Nucleotide related,#b2df8a
740,26,12,HPC: Gas-hexadecane PC_3220,Partition coefficient,#a6cee3
741,26,13,HPC: Gas-hexadecane PC_3022,Partition coefficient,#a6cee3
742,26,14,MLF: Linear free energy000,Hydrogen bond related,#6a3d9a
743,26,15,TraAT: Transition between A and T,Transcript related,#fb9a99
744,26,16,PHB: Potential Hydrogen Bonds_3000,Hydrogen bond related,#6a3d9a
745,26,17,PHB: Potential Hydrogen Bonds_300,Hydrogen bond related,#6a3d9a
746,26,18,MLF: Linear free energy00,Hydrogen bond related,#6a3d9a
747,26,19,LFI: Lipoaffinity index_3011,Solubility lipoaffinity,#33a02c
748,26,20,LFI: Lipoaffinity index011,Solubility lipoaffinity,#33a02c
749,26,21,PCDAA: Parallel correlation PseDN composition of AA,Nucleotide related,#b2df8a
750,26,22,SCCou: Stop codon count,Codon related,#e31a1c
751,26,23,L5UTR: Length of 5 untranslated region,Transcript related,#fb9a99
752,26,24,Base pairs,Secondary structure,#666666
753,26,25,EipAP: Electron-ion interaction pseudopotential average power,EIIP based spectrum,#ffffb3
754,26,26,L3UTR: Length of 3 untranslated region,Transcript related,#fb9a99
755,26,27,0,NaN,#000000
